Innoveren Scientific Statistics
Total Valuation
IVRN has a market cap or net worth of $188. The enterprise value is $3.12 million.
| Market Cap | 188 |
| Enterprise Value | 3.12M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 69.38% |
| Owned by Institutions (%) | n/a |
| Float | 221,934 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.00 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.93 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.12
| Current Ratio | 0.12 |
| Quick Ratio | 0.10 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -28.92 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -777.70% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $807,455 |
| Profits Per Employee | -$3.64M |
| Employee Count | 2 |
| Asset Turnover | 1.72 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -98.85% in the last 52 weeks. The beta is 0.64, so IVRN's price volatility has been lower than the market average.
| Beta (1Y) | 0.64 |
| 52-Week Price Change | -98.85% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.28 |
| Relative Strength Index (RSI) | 38.75 |
| Average Volume (30 Days) | n/a |
Short Selling Information
| Short Interest | 294 |
| Short Previous Month | 275 |
| Short % of Shares Out | n/a |
| Short % of Float | 0.13% |
| Short Ratio (days to cover) | 3.47 |
Income Statement
In the last 12 months, IVRN had revenue of $1.61 million and -$7.28 million in losses. Loss per share was -$30.00.
| Revenue | 1.61M |
| Gross Profit | 1.02M |
| Operating Income | -4.67M |
| Pretax Income | -7.28M |
| Net Income | -7.28M |
| EBITDA | -7.03M |
| EBIT | -7.04M |
| Loss Per Share | -$30.00 |
Balance Sheet
The company has $341,284 in cash and $3.46 million in debt, giving a net cash position of -$3.12 million.
| Cash & Cash Equivalents | 341,284 |
| Total Debt | 3.46M |
| Net Cash | -3.12M |
| Net Cash Per Share | n/a |
| Equity / Book Value | -4.13M |
| Book Value Per Share | n/a |
| Working Capital | -4.22M |
Cash Flow
In the last 12 months, operating cash flow was -$4.39 million and capital expenditures -$6,308, giving a free cash flow of -$4.39 million.
| Operating Cash Flow | -4.39M |
| Capital Expenditures | -6,308 |
| Free Cash Flow | -4.39M |
| FCF Per Share | -$25.97 |
Margins
Gross margin is 63.31%, with operating and profit margins of -289.34% and -451.01%.
| Gross Margin | 63.31% |
| Operating Margin | -289.34% |
| Pretax Margin | -451.01% |
| Profit Margin | -451.01% |
| EBITDA Margin | -435.48% |
| EBIT Margin | -435.94% |
| FCF Margin | -272.06% |
Dividends & Yields
IVRN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.86% |
| Shareholder Yield | -31.86% |
| Earnings Yield | -3,874,157.45% |
| FCF Yield | -2,337,002.13% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 13, 2022. It was a reverse split with a ratio of 1:1000.
| Last Split Date | Jun 13, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:1000 |
Scores
IVRN has an Altman Z-Score of -143.7 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -143.7 |
| Piotroski F-Score | 4 |